Completed PHASE1 INTERVENTIONAL 1-arm NCT01253499

Multiple Dose Study of TRx0037

A Phase 1 Study Consisting of a Double-Blind, Placebo Controlled Multiple Dose Study of TRx0037 in Healthy Elderly Volunteers

Sponsor: Quotient Clinical

Conditions Alzheimer's Disease

Interventions TRx0037

Updated 5 times since 2017 Last updated: Dec 16, 2010 Started: Mar 31, 2010 Primary completion: May 31, 2010 Completion: May 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Alzheimer's Disease and is currently completed. Quotient Clinical leads this study, which shows 5 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Mar 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Quotient Clinical
TauRx Therapeutics Ltd

Data source: TauRx Therapeutics Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.